Terms: = Endocrine gland cancer AND NF1, NFNS, 4763, ENSG00000196712, P21359 AND Prognosis
19 results:
1. Undifferentiated Carcinoma with Osteoclast-like Giant Cells of the Pancreas: Molecular Genetic Analysis of 13 Cases.
Hrudka J; Kalinová M; Ciprová V; Moravcová J; Dvořák R; Matěj R
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542259
[TBL] [Abstract] [Full Text] [Related]
2. Significance of oncocytic features in poorly differentiated thyroid carcinoma - a bi-institutional experience.
Xu B; Lubin DJ; Dogan S; Ghossein RA; Viswanathan K
Virchows Arch; 2023 Mar; 482(3):479-491. PubMed ID: 36346459
[TBL] [Abstract] [Full Text] [Related]
3. Impact of Somatic Mutations on Survival Outcomes in Patients With Anaplastic Thyroid Carcinoma.
Wang JR; Montierth M; Xu L; Goswami M; Zhao X; Cote G; Wang W; Iyer P; Dadu R; Busaidy NL; Lai SY; Gross ND; Ferrarotto R; Lu C; Gunn GB; Williams MD; Routbort M; Zafereo ME; Cabanillas ME
JCO Precis Oncol; 2022 Aug; 6():e2100504. PubMed ID: 35977347
[TBL] [Abstract] [Full Text] [Related]
4. [endocrine and neuroendocrine tumors].
Riss P; Scheuba K; Strobel O
Chirurg; 2021 Nov; 92(11):996-1002. PubMed ID: 34618164
[TBL] [Abstract] [Full Text] [Related]
5. Phakomatoses and endocrine gland Tumors: Noteworthy and (Not so) Rare Associations.
Chevalier B; Dupuis H; Jannin A; Lemaitre M; Do Cao C; Cardot-Bauters C; Espiard S; Vantyghem MC
Front Endocrinol (Lausanne); 2021; 12():678869. PubMed ID: 34025587
[TBL] [Abstract] [Full Text] [Related]
6. [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].
Couvelard A; Scoazec JY
Ann Pathol; 2020 Apr; 40(2):120-133. PubMed ID: 32035641
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic Factors of Malignant Pheochromocytoma and Paraganglioma: A Combined SEER and TCGA Databases Review.
Mei L; Khurana A; Al-Juhaishi T; Faber A; Celi F; Smith S; Boikos S
Horm Metab Res; 2019 Jul; 51(7):451-457. PubMed ID: 30919391
[TBL] [Abstract] [Full Text] [Related]
8. Targeted Molecular Analysis in Adrenocortical Carcinomas: A Strategy Toward Improved Personalized Prognostication.
Lippert J; Appenzeller S; Liang R; Sbiera S; Kircher S; Altieri B; Nanda I; Weigand I; Gehrig A; Steinhauer S; Riemens RJM; Rosenwald A; Müller CR; Kroiss M; Rost S; Fassnacht M; Ronchi CL
J Clin Endocrinol Metab; 2018 Dec; 103(12):4511-4523. PubMed ID: 30113656
[TBL] [Abstract] [Full Text] [Related]
9. Comprehensive Genetic Analysis of Follicular Thyroid Carcinoma Predicts prognosis Independent of Histology.
Nicolson NG; Murtha TD; Dong W; Paulsson JO; Choi J; Barbieri AL; Brown TC; Kunstman JW; Larsson C; Prasad ML; Korah R; Lifton RP; Juhlin CC; Carling T
J Clin Endocrinol Metab; 2018 Jul; 103(7):2640-2650. PubMed ID: 29726952
[TBL] [Abstract] [Full Text] [Related]
10. Neurofibromatosis type 1: a case highlighting pulmonary and other rare clinical manifestations.
Nguyen KA; Elnaggar M; Gallant NM; Tanios M
BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29386211
[TBL] [Abstract] [Full Text] [Related]
11. [Composite pheochromocytoma: A rare adrenal tumor].
Robinet G; Rioux-Leclercq N; Manunta A; Mathieu R; Tissier F; Peyronnet B; Kammerer-Jacquet SF
Ann Pathol; 2017 Apr; 37(2):158-161. PubMed ID: 28285811
[TBL] [Abstract] [Full Text] [Related]
12. Mutational burdens and evolutionary ages of thyroid follicular adenoma are comparable to those of follicular carcinoma.
Jung SH; Kim MS; Jung CK; Park HC; Kim SY; Liu J; Bae JS; Lee SH; Kim TM; Lee SH; Chung YJ
Oncotarget; 2016 Oct; 7(43):69638-69648. PubMed ID: 27626165
[TBL] [Abstract] [Full Text] [Related]
13. Genomic Characterization of High-Grade Serous Ovarian cancer: Dissecting Its Molecular Heterogeneity as a Road Towards Effective Therapeutic Strategies.
Mittempergher L
Curr Oncol Rep; 2016 Jul; 18(7):44. PubMed ID: 27241520
[TBL] [Abstract] [Full Text] [Related]
14. Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas.
Uehara Y; Oda K; Ikeda Y; Koso T; Tsuji S; Yamamoto S; Asada K; Sone K; Kurikawa R; Makii C; Hagiwara O; Tanikawa M; Maeda D; Hasegawa K; Nakagawa S; Wada-Hiraike O; Kawana K; Fukayama M; Fujiwara K; Yano T; Osuga Y; Fujii T; Aburatani H
PLoS One; 2015; 10(6):e0128066. PubMed ID: 26043110
[TBL] [Abstract] [Full Text] [Related]
15. Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies.
Ross JS; Wang K; Rand JV; Gay L; Presta MJ; Sheehan CE; Ali SM; Elvin JA; Labrecque E; Hiemstra C; Buell J; Otto GA; Yelensky R; Lipson D; Morosini D; Chmielecki J; Miller VA; Stephens PJ
J Clin Pathol; 2014 Nov; 67(11):968-73. PubMed ID: 25078331
[TBL] [Abstract] [Full Text] [Related]
16. Long-term prognosis of patients with pediatric pheochromocytoma.
Bausch B; Wellner U; Bausch D; Schiavi F; Barontini M; Sanso G; Walz MK; Peczkowska M; Weryha G; Dall'igna P; Cecchetto G; Bisogno G; Moeller LC; Bockenhauer D; Patocs A; Rácz K; Zabolotnyi D; Yaremchuk S; Dzivite-Krisane I; Castinetti F; Taieb D; Malinoc A; von Dobschuetz E; Roessler J; Schmid KW; Opocher G; Eng C; Neumann HP
Endocr Relat Cancer; 2014 Feb; 21(1):17-25. PubMed ID: 24169644
[TBL] [Abstract] [Full Text] [Related]
17. Hereditary paragangliomas.
Raygada M; Pasini B; Stratakis CA
Adv Otorhinolaryngol; 2011; 70():99-106. PubMed ID: 21358191
[TBL] [Abstract] [Full Text] [Related]
18. Characteristic genomic imbalances in pediatric pheochromocytoma.
Hering A; Guratowska M; Bucsky P; Claussen U; Decker J; Ernst G; Hoeppner W; Michel S; Neumann H; Parlowsky T; Loncarevic I
Genes Chromosomes Cancer; 2006 Jun; 45(6):602-7. PubMed ID: 16518846
[TBL] [Abstract] [Full Text] [Related]
19. New insights in the genetics of adrenocortical tumors, pheochromocytomas and paragangliomas.
Bertherat J; Gimenez-Roqueplo AP
Horm Metab Res; 2005 Jun; 37(6):384-90. PubMed ID: 16001332
[TBL] [Abstract] [Full Text] [Related]
